Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

LIDOCAINE HYDROCHLORID

Active
SPE2DP-27-T-0242Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Solicitation SPE2DP-27-T-0242 is issued by the Defense Logistics Agency for the procurement of Lidocaine Hydrochloride and Dextrose Injection, NSN 6505-01-386-7770. The requirement is for one package containing 24 single-dose 500 ML bags, each with a concentration of 4 mg/mL (2 grams of Lidocaine Hydrochloride USP and 5 grams of Hydrous Dextrose USP). The product must be sterile, nonpyrogenic, and free of latex, DEHP, and PVC. It is subject to a non-extendable shelf life of 30 months and must be stored at 25°C, though it can withstand brief exposure up to 40°C. Delivery is required within 84 days, with the destination and inspection point located in Kaiserslautern, Germany. Packaging must adhere to MIL-STD-2073-1E and special instructions MPPWN00001, while marking must comply with Medical Marking Standard No. 1. The contract incorporates various federal regulations, including the Buy American and Balance of Payments Program for quotes above the micro-purchase threshold and DFARS requirements for safeguarding covered defense information. Invoicing and payment are to be processed electronically via the Wide Area WorkFlow system.

General Info

DLA solicitation for Lidocaine Hydrochloride and Dextrose Injection delivery to Kaiserslautern, Germany.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

ATTN CL VIII MED REQ PROCES ACT, APO, AE, 09227-0000, USA

Set-Aside

NONE

Documents

1
PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Office AddressUSA
Contacts

Full Description

Show more
LIDOCAINE HYDROCHLORIDE AND DEXTROSE INJ
LIDOCAINE HYDROCHLORIDE AND DEXTROSE INJECTION<(>,<)> USP. REPLACEMENT
NSN FOR 6505-01-153-4324. 2 G (4 MG/ML). RX ONLY; FOR INTRAVENOUS USE
ONLY. STERILE AND NONPYROGENIC. SINGLE DOSE CONTAINERS. LATEX-FREE,
DEHP-FREE, AND PVC-FREE. BAG FILL VOLUME: 500 ML. CONTAINS 2 GRAMS OF
LIDOCAINE HYDROCHLORIDE USP, 5 GRAMS OF HYDROUS DEXTROSE USP, AND WATER
FOR INJECTION USP QS. UNIT OF ISSUE IS A PACKAGE CONTAINING 24 EACH
(PLASTIC BAGS OR SINGLE USE CONTAINERS). STORE AT ROOM TEMPERATURE
(25°C); HOWEVER, BRIEF EXPOSURE UP TO 40°C DOES NOT ADVERSELY AFFECT THE
PRODUCT. AVOID EXCESSIVE HEAT. PROTECT FROM FREEZING.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS019: Shelf-life requirement RS001 for a TYPE I (CODE P) item with a shelf life of 30 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
B. BRAUN MEDICAL INC 11171 P/N NDC00264-9594-10 B. BRAUN MEDICAL INC 11171 P/N P5941
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-27-T-0242
SECTION B
PR: 7018997517 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018997517 0001 PG 1.000
NSN/MATERIAL:6505013867770
DELIVERY (IN DAYS):0084
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-386-7770 Quantity: 1 PG Purchase Request: 7018997517QTY: 1 Delivery: 84 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
TRAZODONE TABLETS
Solicitation # SPE2DP-27-T-0239
Solicitation SPE2DP-27-T-0239 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Trazodone Hydrochloride Tablets. The requirement specifies 100 mg tablets supplied in bottles of 100, with a total quantity of two bottles. The product is regulated by the FDA and must have a total shelf life of 24 months, with at least 21 months of shelf life remaining upon delivery to the government. Delivery is required within five days after receipt of order, with the original required delivery date set for November 5, 2026. The point of delivery and the location for both inspection and acceptance is FOB Destination at Fort Bragg, North Carolina. The contractor must adhere to strict packaging and marking standards, specifically Medical Marking Standard No. 1 and 1A, which supersede MIL-STD-129. Packaging must be commercial and include suitable sealed unit containers and exterior shipping containers, with palletization following DLA requirement RP001. If the material is deemed hazardous per FED-STD-313, it must be packaged according to TQ requirement IP025; otherwise, ASTM D3951 applies. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses, including the Buy American Act, safeguarding of covered defense information, and prohibitions on certain telecommunications equipment. Quotes are to be submitted via the DIBBS portal under NAICS code 325412.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 1 hour ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS